Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab

Diabetes Care

Volumn 28, Issue 2, 2005, Pages 445-447

  Sfikakis, Petros P ^a,d   Markomichelakis, Nikos ^b   Theodossiadis, George P ^c   Grigoropoulos, Vlassis ^c   Katsilambros, Nikos ^a   Theodossiadis, Panayiotis G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Gennimatas Hospital   (Greece)

^c Henry Dynan Hospital   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; HUMAN; INFUSION; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA, CYSTOID; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12844263375     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.2.445     Document Type: Article

References (16)

1. Ciulla TA, Amador AG, Zinman B: Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 26:2653-2664, 2003
2. Antcliff RJ, Marshall J: The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14:223-232, 1999
3. Limb GA, Webster L, Soomro H, Janikoun S, Shilling J: Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin Exp Immunol 118:213-218, 1999
4. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH: Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci 42:1586-1591, 2001
5. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M: Activation of nuclear factor-κB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 51:2241-2248, 2002
6. Jonas JB, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61, 2003
7. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, Adamis AP: Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16:438-440, 2002
8. Sfikakis PP, Kollias G: Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15:380-386, 2003
9. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN: Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 358:295-296, 2001
10. Sfikakis PP, Kaklamanis P, Elezoglou A, Katsilambros N, Theodossiadis PG, Papaefthimiou S, Markomichelakis N: Infliximab for recurrent sight-threatening ocular inflammation in Adamantiades-Bechet's disease. Ann Intern Med 140:404-406, 2004
11. Markomichelakis N, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP: Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 138:648-650, 2004
12. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, KOciok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:450-452, 2004
13. Canete JD, Pablos JL, Sanmarti R, Mallofre C, Marsal S, Maymo J, Gratacos J, Mezquita J, Mezquita C, Cid MC: Antiangiogenic effects of anti-tumor necrosis factor alpha therapy with infliximab in psoriatic arthritis. Arthritis Rheum 50:1636-1641, 2004
14. Armstrong D, Augustin AJ, Spengler R, Al Jada A, Nickola T, Grus F, Koch F: Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 212:410-414, 1998
15. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E, Hori S: Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135:321-327, 2003
16. Saichin Y, Saichin Y, Takahasci K, Lima e Silva R, Hylton D, Rudge JS, Wiegand SJ, Campochiaro PA: VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195: 241-248, 2003